These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 9199125)

  • 1. [Comparative pharmacokinetics of theophylline in hyperlipidemia in animals and humans].
    Górnik W
    Ann Acad Med Stetin; 1996; 42():39-50. PubMed ID: 9199125
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The pharmacokinetics of phenytoin in rabbits with hyperlipidemia induced by high-fat diet.
    Droździk M; Gawrońska-Szklarz B; Wójcicki J
    Acta Pol Pharm; 1994; 51(6):517-9. PubMed ID: 7762402
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative pharmacokinetics of propranolol and atenolol in primary hyperlipidemia.
    Telatyńska B; Wójcicki J; Droździk M; Gawrońska-Szklarz B; Sulzyc-Bielicka V; Sterna R
    Pol J Pharmacol; 2003; 55(1):81-9. PubMed ID: 12856830
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative pharmacokinetics of theophylline in rabbits and in humans with hyperlipidemia.
    Wójcicki J; Górnik W; Pawlik A; Droździk M; Gawrońska-Szklarz B
    Pulm Pharmacol; 1996 Jun; 9(3):175-8. PubMed ID: 8948514
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of experimental hyperlipidemia on the pharmacokinetics of digoxin.
    Gawrońska-Szklarz B; Drozdzik M; Wójcicki J; Zakrzewski J
    Acta Pol Pharm; 1994; 51(3):271-4. PubMed ID: 7872019
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The effect of hypolipemic treatment on the pharmacokinetics of propranolol].
    Sterna R
    Ann Acad Med Stetin; 1997; 43():67-77. PubMed ID: 9471924
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Pharmacokinetic comparison of propranolol and atenolol in people with primary hypertension].
    Telatyńska-Smieszek B
    Ann Acad Med Stetin; 2002; 48():367-80. PubMed ID: 14601489
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effect of hydroxylation polymorphism on the concentration of propranolol in the blood of humans with hyperlipidemia].
    Sulzyc-Bielicka V; Droździk M; Gawrońska-Szklarz B; Sterna R; Wójcicki J; Kunicki P; Sitkiewicz D
    Pol Merkur Lekarski; 1999 Dec; 7(42):256-8. PubMed ID: 10710948
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The effect of experimental extrahepatic cholestasis on absorption, distribution and elimination of digoxin].
    Wójcicki M
    Ann Acad Med Stetin; 1996; 42():51-65. PubMed ID: 9199126
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics of Amiodarone in hyperlipidemic and simulated high fat-meal rat models.
    Shayeganpour A; Jun AS; Brocks DR
    Biopharm Drug Dispos; 2005 Sep; 26(6):249-57. PubMed ID: 15968713
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NTP technical report on the toxicity studies of Dibutyl Phthalate (CAS No. 84-74-2) Administered in Feed to F344/N Rats and B6C3F1 Mice.
    Marsman D
    Toxic Rep Ser; 1995 Apr; 30():1-G5. PubMed ID: 12209194
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative pharmacokinetics of doxycycline and oxytetracycline in patients with hyperlipidemia.
    Wójcicki J; Kalinowski W; Gawrońska-Szklarz B
    Arzneimittelforschung; 1985; 35(6):991-3. PubMed ID: 4026928
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Final report on the safety assessment of capsicum annuum extract, capsicum annuum fruit extract, capsicum annuum resin, capsicum annuum fruit powder, capsicum frutescens fruit, capsicum frutescens fruit extract, capsicum frutescens resin, and capsaicin.
    Int J Toxicol; 2007; 26 Suppl 1():3-106. PubMed ID: 17365137
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Altered dose-to-effect of propofol due to pharmacokinetics in rats with experimental diabetes mellitus.
    Leal N; Calvo R; Agrad FZ; Lukas JC; de la Fuente L; Suarez E
    J Pharm Pharmacol; 2005 Mar; 57(3):317-25. PubMed ID: 15807987
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics and pharmacodynamics of nifedipine in untreated and atorvastatin-treated hyperlipidemic rats.
    Eliot LA; Jamali F
    J Pharmacol Exp Ther; 1999 Oct; 291(1):188-93. PubMed ID: 10490903
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of the effect of 3 different diets on the bioavailability of 2 sustained release theophylline matrix tablets.
    Gai MN; Isla A; Andonaegui MT; Thielemann AM; Seitz C
    Int J Clin Pharmacol Ther; 1997 Dec; 35(12):565-71. PubMed ID: 9455715
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NTP technical report on the toxicity and metabolism studies of chloral hydrate (CAS No. 302-17-0). Administered by gavage to F344/N rats and B6C3F1 mice.
    Beland FA
    Toxic Rep Ser; 1999 Aug; (59):1-66, A1-E7. PubMed ID: 11803702
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effect of propranolol on lidocaine pharmacokinetics].
    Gawrońska-Szklarz G; Bijoś P; Feszak J; Droździk M; Goertz K; Wójcicki J
    Pol Tyg Lek; 1990 Jun 4-11; 45(23-24):473-5. PubMed ID: 2277792
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NTP Toxicology and Carcinogenesis Studies of Theophylline (CAS No. 58-55-9) in F344/N Rats and B6C3F1 Mice (Feed and Gavage Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1998 Aug; 473():1-326. PubMed ID: 12571677
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics of intranasal and intratracheal pentoxifylline in rabbits.
    Adcock KG; Kyle PB; Deaton JS; Olivier JH; Hogan SM
    Pharmacotherapy; 2007 Feb; 27(2):200-6. PubMed ID: 17253910
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.